| Zugriffe | |
|---|---|
| Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report | 113 |
| Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report | 33 | 2 | 0 | 10 | 5 | 7 | 7 |
| Zugriffe | |
|---|---|
| 2022_Ehret_etal.pdf | 125 |
